Realizing the potential of device technologies in cardiovascular and orthopaedic medicine
For nearly two decades, BioStar Capital has been at the forefront of investing in disruptive cardiovascular and orthopaedic medical technologies. The BioStar team combines the insight of experienced investment professionals with the expertise of world-renowned medical thought leaders in clinical practice to attract unique deal flow, mitigate investment risk, optimize product development, and secure successful exit.
BioStar Capital pursues this vision by ensuring that its strategic investments:
Address unmet medical or health economic needs
Improve patient care, quality of life, and/or longevity in a cost-effective manner
Generate profitable returns for investors
Are managed with uncompromising integrity and skill
BioStar Capital Encourages Entrepreneurs to Apply for Funding